grant

Understanding the effect of Hao-Fountain syndrome-causing mutations on neuronal development

Organization UNIVERSITY OF CONNECTICUT SCH OF MED/DNTLocation FARMINGTON, UNITED STATESPosted 1 Aug 2024Deadline 30 Jun 2026
NIHUS FederalResearch GrantFY20240-11 years old3-D3-Dimensional3DAPF-1ASDATP-Dependent Proteolysis Factor 1AccelerationAffectAngelman SyndromeAssayAutismAutistic DisorderAutoregulationBehavioralBioassayBiologic ModelsBiological AssayBiological ModelsBrainBrain Nervous SystemCatalytic CoreCatalytic DomainCatalytic RegionCatalytic SiteCatalytic SubunitCell Culture TechniquesCell DifferentiationCell Differentiation processCell modelCellular modelChildChild YouthChildhoodChildren (0-21)Chromosome 16CommunitiesComplexDecreased Muscle ToneDefectDeubiquitinating EnzymeDeubiquitinationDevelopmentDevelopmental DelayDevelopmental Delay DisordersDiseaseDisease PathwayDisorderDown's SyndromeDysfunctionEarly Infantile AutismEncephalonEnzyme KineticsEvaluationFetusFibroblastsFountain syndromeFunctional disorderFutureGenesGenetic AlterationGenetic ChangeGenetic defectGliaGlial CellsGoalsHDM2HMG-20Happy Puppet SyndromeHigh Mobility Protein 20HistonesHomeostasisHumanHypomyotoniaHypotoniaImmunoblottingIn VitroInduced pluripotent stem cell derived neuronsInfantile AutismIntellectual disabilityIntellectual functioning disabilityIntellectual impairmentIntellectual limitationKanner's SyndromeKolliker's reticulumLangdon Down syndromeLengthLinkMDM2MDM2 geneMDMX proteinMR ImagingMR TomographyMRIMRIsMagnetic Resonance ImagingMaintenanceMdm-2 proteinMeasuresMedical Imaging, Magnetic Resonance / Nuclear Magnetic ResonanceMethodsModel SystemModelingModern ManMolecularMongolismMorphologyMuscle HypotonyMuscle Tone PoorMuscle hypotoniaMuscular HypotoniaMutationNMR ImagingNMR TomographyNerve CellsNerve UnitNeural CellNeural DevelopmentNeural Stem CellNeuritesNeurocyteNeurodevelopmental DisorderNeurogliaNeuroglial CellsNeurological Development DisorderNeuron from iPSCNeuron from induced pluripotent stem cellsNeuronal DifferentiationNeuronsNon-neuronal cellNonneuronal cellNuclear Magnetic Resonance ImagingOncoprotein MDM2OrganoidsParentsPathogenicityPathway interactionsPatientsPhysiological HomeostasisPhysiopathologyProgenitor CellsProteinsPuppet ChildrenRegulationReportingResearchResearch ResourcesResourcesRodent ModelSamplingSchizophreniaSchizophrenic DisordersSeizuresSpecific Child Development DisordersSpeech DelayStructureTestingTherapeuticTimeTrisomy 21UbiquitilationUbiquitinUbiquitinationUbiquitinoylationVariantVariationWestern BlottingWestern ImmunoblottingWorkZeugmatographyautism modelautism spectral disorderautism spectrum disorderautistic spectrum disordercell culturecell culturescellular differentiationchromosome 21 trisomy syndromecongenital acromicria syndromede-ubiquitinasede-ubiquitinating enzymedementia praecoxdevelopmentaldisease modeldisorder modelenzyme activityfeedinggenome mutationglobal developmental delayhuman diseaseiPSiPS neuronsiPSCiPSC derived-neuronsiPSCsimpairment in intelligencein vitro activityinduced pluripotent cellinduced pluripotent stem cellinduced pluripotent stem cell neuronsinduced pluripotent stem cells derived from patientsinduced pluripotent stem cells from patientsinducible pluripotent stem cellinhibitorintellectual and developmental disabilitykidslimited intellectual functioningmdm-2 oncogene proteinmdm2 proteinmodel of autism spectrum disordermorbus Downmutantnerve cementnerve stem cellneural precursorneural precursor cellneural progenitorneural progenitor cellsneurodevelopmentneurodevelopmental diseaseneuron developmentneuron progenitorsneuronalneuronal developmentneuronal progenitorneuronal progenitor cellsneuronal stem cellsneurons derived from induced pluripotent stem cellsneuroprogenitoroverexpressoverexpressionp53-Binding Protein MDM2parentpathophysiologypathwaypatient derived human iPSpatient derived human iPSCpatient derived human induced pluripotent stem cellpatient derived iPSpatient derived iPSCpatient derived induced pluripotent cellspatient derived induced pluripotent stem cellspatient-derived pluripotent stem cellspediatricpersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentpreventpreventingprogenitor cell differentiationprogenitor cell modelprogenitor differentiationprogenitor modelprotein blottingprotein homeostasisproteostasispseudohypertrophic progressive muscular dystrophypuppetlike syndromeschizophrenicself-renewself-renewalstem and progenitor cell modelstem and progenitor differentiationstem cell based modelstem cell derived modelstem cell differentiationstem cell modelstem cellssuccesstherapeutic targetthree dimensionaltreatment strategytrisomy 21 syndromeubiquinationubiquitin conjugationubiquitin isopeptidaseubiquitin-specific isopeptidaseubiquitin-specific proteaseyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
Hao-Fountain syndrome is a newly identified rare pediatric neurodevelopmental disorder caused by deletions

and mutations of the USP7 gene. The molecular mechanisms and pathophysiology of the disease remain poorly

understood, preventing the development of potential treatments for Hao-Fountain patients. USP7 is a

deubiquitinating enzyme implicated in the maintenance of protein homeostasis, stem cell identity, self-renewal,

and control of dendritic branching in primary neurons. A model system has not yet been created but is

indispensable for understanding the disease and for the evaluation of potential personalized therapies for Hao-

Fountain Syndrome. In this proposal, we will create the first human-based cellular model of Hao-Fountain to test

the effect of disease-linked mutations on the enzymatic function of USP7 (Aim 1), and on neuron differentiation

potential and morphology (Aim 2). The patient-derived induced pluripotent stem cells will be differentiated into

cortical neurons to create the Hao-Fountain model system that will be shared with the greater community to

accelerate the understanding of this newly discovered and devastating disease.

Grant Number: 1R21NS135343-01A1
NIH Institute/Center: NIH

Principal Investigator: Irina Bezsonova

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Understanding the effect of Hao-Fountain syndrome-causing mutations on neuronal development — UNIVERSITY OF CONNECTICUT | Dev Procure